# The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.

Study · id `cardio:ct-nct07513883` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07513883](<https://clinicaltrials.gov/study/NCT07513883>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07513883

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07513883. Randomized; single masking; primary purpose treatment. Start 2026-03-16 (actual); primary completion 2028-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07513883, source copy `cardio:ctgov-nct07513883-2026-04-07`, retrieved 2026-10-26)
- Started: 2026-03-16 (actual) (ClinicalTrials.gov record NCT07513883, source copy `cardio:ctgov-nct07513883-2026-04-07`, retrieved 2026-10-26)
- Primary completion: 2028-09 (anticipated) (ClinicalTrials.gov record NCT07513883, source copy `cardio:ctgov-nct07513883-2026-04-07`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07513883, source copy `cardio:ctgov-nct07513883-2026-04-07`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT07513883, source copy `cardio:ctgov-nct07513883-2026-04-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07513883-2026-04-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.
- Acronym: TAPERED-HF
- Condition: Heart Failure
- Intervention (Drug): Down-titration
- Intervention (Drug): Continuation of guideline-directed heart failure therapy
- Lead sponsor: Ziekenhuis Oost-Limburg
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Ziekenhuis Oost-Limburg (`cardio:org-ziekenhuis-oost-limburg`)

## Provenance

Content hash: af23e4a05393efbce70ffcf34409fae2db19e9e0c85c8eeec66d6c3eaea01447
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
